Polatuzumab vedotin plus rituximab and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 study
| Autor: | Abrisqueta, Pau, González-Barca, Eva, Panizo, Carlos, Pérez, José María Arguiñano, Miall, Fiona, Bastos-Oreiro, Mariana, Triguero, Ana, Banerjee, Lalita, McMillan, Andrew, Seymour, Erlene, Hirata, Jamie, de Guzman, Jayson, Sharma, Sunil, Jin, Hyun Yong, Musick, Lisa, Diefenbach, Catherine * |
|---|---|
| Zdroj: | In The Lancet Haematology February 2024 11(2):e136-e146 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|